platoseedplatoseed
Catheter-based solution to treat chronic heart failure.
Our device catheter-based device is able to safely perform a targeted nerve ablation in the upper abdomen. Cardiologists are concerned about collateral tissue damage in ablation procedures - our probe not only targets a very specific area, but also confirms that it’s done correctly.
Corveus Medical is developing a minimally-invasive catheter-based solution to deactivates a nerve driving heart failure, enabling physicians to treat patients with limited options and improve quality of life. The approach uses the body's venous anatomy to reach and ablate a target nerve and confirms full nerve deactivation during the procedure.
A catheter-based system that reaches a target sympathetic nerve branch via the venous anatomy, performs ablation to deactivate the nerve, and provides intra-procedural confirmation of complete nerve deactivation to ensure lasting benefit for patients with moderate heart failure.
funding/hiring mentions
Formerly “Caridian Medical” · why startups rename →
High-precision, closed-loop neuromodulation devices
One-time, device-based treatment for heart failure
